Strategic Advisor Agreement Sample Contracts

Re: Strategic Advisor Agreement
Strategic Advisor Agreement • April 7th, 2017 • Cinedigm Corp. • Services-video tape rental • Illinois

This letter (the “Agreement”) sets forth our agreement regarding the terms and conditions of your retention as a strategic advisor by Cinedigm Corp. (the “Company”). You and the Company agree as follows:

AutoNDA by SimpleDocs
VITAL LIVING, INC. Strategic Advisor Agreement
Strategic Advisor Agreement • December 5th, 2003 • Vital Living Inc • Pharmaceutical preparations • California

This Corporate Strategic Advisor Agreement (SAA) (“Agreement”) dated October 14, 2003, (the “Effective Date”) is made by and between Vital Living, Inc., a Nevada corporation, whose address is 5080 N. 40th Street, #105, Phoenix, Arizona, 85018 (“Company” or “Vital Living”), and (ii) Dr. Roger Howe (“Consultant”), an individual whose address is 667 Lynwood Drive, Encinitas, California 92024

STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • November 14th, 2017 • aTYR PHARMA INC • Biological products, (no disgnostic substances)
Strategic Advisor AGREEMENT
Strategic Advisor Agreement • February 26th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut

This Strategic Advisor Agreement (this “Agreement”) between Vince O’Neill having a mailing address at 125 Redbud Trl, West lake Hills TX 78746 (the “Strategic Advisor”), and BioXcel Therapeutics, Inc., a Delaware corporation having a principal place of business at 780 East Main Street, Branford, Connecticut 06405 (the “Company”), is made effective as of July 10th, 2017 (the “Effective Date”). In connection with the appointment of the Strategic Advisor to the Company and the mutual promises of the parties hereunder, it is agreed as follows:

February 21,200l Mr. Stephen Shulman CEO & President / Director Power Efficiency Corporation 4220 Varsity Drive, Suite E Ann Arbor, Michigan 48108 Dear Steve,
Strategic Advisor Agreement • October 31st, 2001 • Allen Test Co Inc & Point Release Test 10/08/01

This letter amends and restates an arrangement between ARl Group on the one hand and Power Efficiency Corporation on the other hand.

STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • June 22nd, 2021 • Wm Technology, Inc. • Services-prepackaged software • California

THIS STRATEGIC ADVISOR AGREEMENT (“Agreement”) is made and entered into between Ghost Management Group, LLC, a Delaware limited liability company (the “Company”), on the one hand, and Steven Jung, an individual (“Employee”), on the other hand. Each of Company and Employee may be referred to individually as a “Party” and collectively as the “Parties.”

From: Neil Morganbesser <nm@delmorganco.com>
Strategic Advisor Agreement • June 9th, 2021 • Leisure Acquisition Corp. • Pharmaceutical preparations
STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • February 8th, 2024 • Intapp, Inc. • Services-prepackaged software • California

This STRATEGIC ADVISOR AGREEMENT (the “Advisor Agreement”) is entered into effective January 1, 2024, between Intapp, Inc., a Delaware corporation (the “Company”) and Stephen Robertson (“Consultant,” and collectively with the Company, the “Parties”).

BioXcel Therapeutics Inc. FIRST AMENDMENT TO STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • February 26th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut

This AMENDMENT (the “Amendment”) to the Strategic Advisor Agreement (the “Agreement”), dated July 10, 2017, by and between BioXcel Therapeutics Inc, a Delaware corporation having a principal place of business at 780 East Main Street, Branford, Connecticut (the “Company”) and Vince O’Neil (the “Strategic Advisor”) is dated as of January 22, 2018 (the “Amendment Effective Date”). Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.

Strategic Advisor Agreement
Strategic Advisor Agreement • July 20th, 2023 • Talaris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

This Advisor Agreement (the “Agreement”), dated as of May 26, 2023 (the “Effective Date”) is between Talaris Therapeutics, Inc., a Delaware corporation with a principal office address at 570 S. Preston Street, Suite 400, Louisville, KY, 40202, Louisville, KY, 40202 (the “Company”) and Scott Requadt, an independent advisor with an address at 15 Lewis Path, Wayland, MA 01778 (“Advisor”). Reference is made to the Severance Agreement and General Release between Advisor and the Company (the “Severance Agreement”), which remains in full effect.

STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • March 1st, 2023 • Enviva Inc. • Lumber & wood products (no furniture)

THIS STRATEGIC ADVISOR AGREEMENT (this “Agreement”) is entered into as of November 14, 2022 but effective as of November 15, 2022 (the “Effective Date”), by and between Enviva Inc., a Delaware corporation with a principal executive office at 7272 Wisconsin Ave., Suite 1800, Bethesda, MD 20814 (“Enviva”), and John K. Keppler (the “Consultant” and, together with Enviva, each a “Party” and collectively the “Parties”).

PUBMATIC STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • May 9th, 2023 • PubMatic, Inc. • Services-computer programming, data processing, etc. • New York
CONFIDENTIAL
Strategic Advisor Agreement • May 2nd, 2016 • Wound Management Technologies, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York

This letter agreement (this “Agreement”) confirms our understanding with respect to your engagement of Evolution Venture Partners LLC (“EVP”) to serve as a “Strategic Advisor” with respect to the matters set forth herein to Wound Management Technologies, Inc. (“WNDM”) and its subsidiaries and affiliates (together with such subsidiaries and affiliates, the “Company”). EVP is not a registered broker-dealer with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”), any state or otherwise, and any services related to the placement of any securities in connection with the consummation of any Financing Transaction, or otherwise, shall be performed by Middlebury Securities, LLC (“Middlebury”, and together with EVP, the “Service Provider”), as further set forth in this Agreement. Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 5.

Re: Amendment to Strategic Advisor Agreement
Strategic Advisor Agreement • August 25th, 2023 • Talaris Therapeutics, Inc. • Biological products, (no disgnostic substances)

This letter (the “Amendment”) amends the terms of your Strategic Advisor Agreement with Talaris Therapeutics, Inc., (the “Company”), dated May 26, 2023 (the “Advisor Agreement”). Capitalized terms not defined herein shall have the meaning specified in the Advisor Agreement. This Amendment represents the mutual written assent referenced in Section 2 of the Advisor Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!